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A report on the International Conference on Microbial
Genomics, Halifax, Canada, 13-16 April 2005.
It is now a decade since the first microbial genome was
sequenced. Although genomics is still in its infancy and the
best is (hopefully!) still to come, amazing strides have been
made since the completion in 1995 of the first genome
sequence of a free-living organism, the bacterium
Haemophilus influenzae. Just ten years later, 261 microbial
genomes have been completed and an additional 669 are in
progress. We have progressed from sequencing a single
bacterial isolate, assuming that it was an adequate refer-
ence for that species, to metagenomics - sequencing an
entire microbial community. We are just starting to discover
the complexity and dynamic nature of the microbial world,
which raises further questions. For example, what is a bac-
terial species? How many isolates need to be sequenced to
capture the diversity of a single species? During the course
of the recent International Conference on Microbial
Genomics held in Canada, the question of “what is a bacterial
species” was raised and discussed on many occasions. As
pointed out by W. Ford Doolittle (Dalhousie University,
Halifax, Canada), the notion of a bacterial species is classi-
cally defined as a “uniform and stable way for naming
groups of similar bacteria”. On the genetic level, it is well
accepted that two isolates are part of the same species if
their 16S rRNA genes share at least 98% identity. This def-
inition is not, however, a good predictor of ecological and
phenotypic differences. Furthermore, recombination and
gene transfer among prokaryotes, as revealed by genomic,
and more recently metagenomic, studies, create further dif-
ficulties in describing a microbial species. The concept of a
bacterial species appears to take different forms depending
on the scientific perspective. Genomic and clinical examina-
tions of Escherichia coli and Shigella species clearly reveal
significant differences, leading to subclassification based on
gene content and disease presentation; comparison of the 16S
rRNA sequences, however, clearly indicate that E. coli and
Shigella are the same species.
In his talk, Doolittle discussed the species concept in relation
to genomic data. He pointed out that while many people
had felt that genomics would clarify the species concept in
prokaryotes, it has actually done the exact opposite and
made it harder to define. Large-scale genomic projects have
identified an unexpected level of diversity among bacteria,
which can often be linked to recombination and gene trans-
fer between a variety of prokaryotic organisms. Thus, the
use of reproductive barriers as a method of speciation in
bacteria cannot be supported. Doolittle noted, however,
that bacteria will fall into natural groups or clusters
depending on the environment, the availability of other
organisms with which to exchange DNA, and how readily
each organism accepts the exchange of DNA. The concept of
a ‘species’ was acknowledged to be necessary for compara-
tive purposes; nevertheless, it probably does not have any
reality at the level of the genome.
In her keynote presentation, Claire Fraser (The Institute for
Genomic Research (TIGR), Rockville, USA) highlighted
work at TIGR, starting from the genome of H. influenzae in
1995 to the current projects, one of which is to determine
the number of genomes that need to be sequenced in order
to assess the variability within any given species. It is clear
that a species is not adequately represented by a single
genome unless the species is evolutionarily young and rela-
tively monomorphic. In the more diverse species, it seems
as though each individual genome provides some unique
information. The number of unique regions gets smaller
with each genome sequenced, until a point of diminishingreturns is reached. This point appears to be unique to each
species. According to James Tiedje (Michigan State Univer-
sity, East Lansing, USA), 13-15 genomes per species need to
be explored to get 95% of the species gene pool, assuming
that the strains chosen adequately represent the ecological
diversity of the species. But there are exceptions, depending
on the level of diversity (ecological niches, pathogen or non-
pathogen, and so on) within a single species.
Metagenomic reconstruction has been taken to another
level by Denis Le Paslier (Genoscope, Evry, France) using
an iterative assembly process that uses cosmid sequencing
data as a seed for building genome assemblies. This
process has the advantage of being able to assemble larger
and larger DNA fragments until a genome is complete or
close to complete. He described how this approach led to
the assembly of the genome of a virtual organism, sug-
gested to be a free-living Gram-negative bacterium, with a
2.25 megabase (Mb) genome containing two rRNAs and 45
tRNAs. This method appears to be a promising way of
assembling large genomic regions from organisms that
cannot be cultured.
Eddy Rubin (US Department of Energy Joint Genome Insti-
tute (JGI), Walnut Creek, USA) described some of the
metagenomic sequencing projects ongoing at JGI. One is a
study comparing high- and low-nutrient environments:
Wisconsin farm soil and Iron Mountain acid mine drainage,
respectively. The results show that the high-nutrient envi-
ronment (Wisconsin farm soil) contains many more species
than the low-nutrient environment. This breadth of species
diversity makes it difficult to assemble DNA shotgun frag-
ments into large contiguous pieces, resulting in an inability
to identify the dominant species. Rubin also described
another JGI metagenomics project, which is studying deep-
sea whale-fall regions, where whale carcasses have sunk to
the sea floor. These environments are rich in lipid, and DNA
encoding metabolic processes could be identified in
samples that were geographically distinct but had similar
nutrient content. In particular, two whale-fall regions sepa-
rated by more than 8,000 miles contained similar func-
tional genomic profiles when metagenomic data was
analyzed using clusters of orthologous groups (COGs). As
Rubin pointed out, identification of a functional process in
a metagenomic project may lead to the recognition and
study of a factor that was not previously examined in this
environment. These functional identifications and sequence
distributions could also be used as ‘environmental genomic
tags’ (or EGTs, by analogy with ESTs, expressed sequence
tags) that are representative of a particular environment. 
Lindsay Eltis (University of British Columbia, Vancouver,
Canada) highlighted further the functional genomic work
that can take place once a genome has been sequenced. His
work on Rhodococcus sp. RHA1, whose 9.7 Mb genome is
composed of a linear chromosome (7.8 Mb) and three linear
plasmids, raises the question of why this genome is so large,
as there appears to be no obvious biological reason. The
genome does not contain a large number of repeated elements,
but does have genes for more than 25 non-ribosomal
peptide synthetases and seven polyketide synthases, which
tend to be large genes (more than 25 kb long). Interestingly,
Rhodococcus RHA1 has never been shown to produce the
products of these genes or the products of the enzymes’
action, which are often biologically active compounds of
pharmaceutical interest such as antibiotics and other drugs.
In contrast, genes from Streptomyces have been shown to
be expressed when introduced into Rhodococcus RHA1. 
The tick-borne bacterial pathogen of cattle, Anaplasma
marginale, can undergo significant antigenic variation.
During an infection, bacteria expressing variants of a major
surface antigen emerge. Guy Palmer (Washington State
University, Pullman, USA), moving further down the path
from sequence to function, discussed the unique method of
variation employed by this pathogen. The small genome
size (1.2 Mb) and the lack of plasmids or phage rule out
antigenic variation by the recombination of complete
pseudogenes from other genomic locations. This lack of
extrachromosomal material suggests that the antigenic
variation would have to come from within the existing
genetic material. A number of short pseudogene segments
were identified within the genome. It is these small segments
that can recombine with the functional gene to create the
antigenic variants. The accumulation of these recombina-
tion events over the course of an infection leads to increased
antigenic presentation and the establishment of a low-level
chronic disease.
The first decade of the genomics era has revolutionized our
understanding of microbiology, and it is very likely that
this process will accelerate, as new technologies are being
developed that allow even more rapid generation of
genomic data, which in turn will open more avenues of
research. We are, however, currently only taking snapshots,
not yet making movies. The challenge of the next decade
will be to string all these pictures together, to really appreciate
the complexity and the dynamic nature of the exchanges
that are taking place in the microbial world and their func-
tional implications.
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